Interleukin-1β sensitizes abdominal visceral afferents of cats to ischaemia and histamine

被引:30
作者
Fu, LW
Longhurst, JC
机构
[1] Univ Calif Irvine, Coll Med, Dept Med, Irvine, CA 92697 USA
[2] Univ Calif Davis, Dept Internal Med & Human Physiol, Davis, CA 95616 USA
来源
JOURNAL OF PHYSIOLOGY-LONDON | 1999年 / 521卷 / 01期
关键词
D O I
10.1111/j.1469-7793.1999.00249.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
1. Activation of abdominal splanchnic visceral afferents during mesenteric ischaemia induces visceral pain and evokes excitatory cardiovascular responses. Previous studies have shown that interleukin-1 beta (IL-1 beta) concentration is increased locally in tissues during ischaemia and reperfusion. Local administration of IL-1 beta sensitizes somatic afferents to mechanical, thermal. and chemical stimulation. Therefore, we hypothesized that IL-1 beta stimulates or sensitizes splanchnic visceral afferents to ischaemia and to the action of chemical stimuli such as histamine. 2. The concentration of IL-1 beta in mesenteric lymph and portal venous plasma in anaesthetized cats was measured with an enzyme-linked immunosorbent assay before, during and after 10 min of abdominal ischaemia. The level of IL-1 beta was significantly increased during ischaemia in lymph, but not in plasma. 3. Discharge activity of single-unit abdominal visceral C fibre afferents was measured from the right thoracic sympathetic chain. Ischaemically sensitive C fibre afferents were identified according to their response to 5-10 min of abdominal ischaemia. 4. Intra-arterial (I.A.) injection of a high dose of IL-1 beta (500 ng kg(-1)), but not of a lower dose (i.e. 15, 50 or 150 ng kg(-1)), stimulated most (six of seven) abdominal visceral afferents. 5. IL-1 beta (15 ng kg(-1), I.A.) significantly enhanced the increased activity of 11 of 13 C fibre afferents during 10 min of ischaemia. Conversely, an IL-1 type I receptor antagonist (IL-1ra, 1.5 mu g kg(-1), I.A.) significantly attenuated the increased activity in six of seven other C fibre afferents during ischaemia. 6. IL-1 beta (15 ng kg(-1), I.A.) significantly augmented the responses of 13 of 16 ischaemically sensitive abdominal afferents to histamine (5-10 mu g kg(-1), I.A.). Conversely, IL-1ra (1.5 mu g kg(-1), I.A.) significantly attenuated the responses of five of six other C fibre afferents to histamine. 7. These data strongly suggest that stimulation of IL-1 type I receptors by IL-1 beta produced during brief abdominal ischaemia contributes to activation of visceral afferents during ischaemia, at least in part, by sensitizing the afferent nerve endings to ischaemia. Our data also show that exogenous IL-1 beta sensitizes visceral afferents to histamine.
引用
收藏
页码:249 / 260
页数:12
相关论文
共 38 条
  • [1] ENDOGENOUS CYTOKINE ANTAGONISTS DURING MYOCARDIAL-ISCHEMIA AND THROMBOLYTIC THERAPY
    AIRAGHI, L
    LETTINO, M
    MANFREDI, MG
    LIPTON, JM
    CATANIA, A
    [J]. AMERICAN HEART JOURNAL, 1995, 130 (02) : 204 - 211
  • [2] QUANTIFICATION OF HUMAN DYNAMIC MUSCLE FATIGUE BY ELECTROMYOGRAPHY AND KINEMATIC PROFILES
    ARENDTNIELSEN, L
    SINKJAER, T
    [J]. JOURNAL OF ELECTROMYOGRAPHY AND KINESIOLOGY, 1991, 1 (01) : 1 - 8
  • [3] Ascer E, 1992, Ann Vasc Surg, V6, P69, DOI 10.1007/BF02000671
  • [4] Clavien PA, 1996, HEPATOLOGY, V23, P1456, DOI 10.1002/hep.510230623
  • [5] HISTAMINE STIMULATION OF INOSITOL 1-PHOSPHATE ACCUMULATION IN LITHIUM-TREATED SLICES FROM REGIONS OF GUINEA-PIG BRAIN
    DAUM, PR
    DOWNES, CP
    YOUNG, JM
    [J]. JOURNAL OF NEUROCHEMISTRY, 1984, 43 (01) : 25 - 32
  • [6] THE INVOLVEMENT OF BRADYKININ B-1 AND B-2 RECEPTOR MECHANISMS IN CYTOKINE-INDUCED MECHANICAL HYPERALGESIA IN THE RAT
    DAVIS, AJ
    PERKINS, MN
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (01) : 63 - 68
  • [7] deKleijn EMHA, 1997, J INFECT DIS, V175, P1027
  • [8] Circulating and ex vivo production of pyrogenic cytokines and interleukin-1 receptor antagonist in 123 patients with fever of unknown origin
    deKleijn, EMHA
    Drenth, JPH
    Pesman, GJ
    vanDruten, H
    Demacker, PNM
    vanderMeer, JWM
    deKleijn, EMHA
    vanderMeer, JWM
    Demacker, P
    Corstens, FHM
    Meinders, AE
    Pauwels, EKJ
    Vandenbroucke, JP
    vanEer, M
    Kreeftenberg, HG
    Piers, DR
    Speelman, P
    vanRoyen, EA
    Claessen, F
    Teule, GJJ
    deMarie, S
    Krenning, EP
    Schneider, M
    Hoepelman, A
    vanRijk, PP
    vanderGeest, S
    Heidendal, GAK
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (01) : 191 - 195
  • [9] Biologic basis for interleukin-1 in disease
    Dinarello, CA
    [J]. BLOOD, 1996, 87 (06) : 2095 - 2147
  • [10] Ek M, 1998, J NEUROSCI, V18, P9471